Catalog No.S1778 Synonyms: NSC 529182, NSC 75520
Molecular Weight(MW): 296.2
Trifluridine is an anti-herpesvirus antiviral agent by interacting viral DNA replication, used primarily on the eye.
Purity & Quality Control
Choose Selective DNA/RNA Synthesis Inhibitors
|Description||Trifluridine is an anti-herpesvirus antiviral agent by interacting viral DNA replication, used primarily on the eye.|
Trifluridine inhibits proliferations of mouse bone marrow cells and human colorectal carcinoma cells implanted to nude mice dose-dependently. Trifluridine inhibits colony formation of bone marrow cells in a concentration-dependent manner.  Trifluridine (FTD) and 2'-deoxy-5-fluorouridine (FdUrd) are incorporated into DNA with different efficiencies due to differences in the substrate specificities of TK1 and DUT, causing abundant FTD incorporation into DNA. FTD-treated cells shows differing nuclear morphologies compared to FdUrd-treated cells.  Trifluridine inhibits proliferations of mouse bone marrow cells and human colorectal carcinoma cells implanted to nude mice dose-dependently. 
|In vivo||Trifluridine has significantly fewer swabs positive for HSV-1 than the untreated eyes in the infected rabbits.  Trifluridine has increased antitumor activity and is incorporated into DNA more effectively than continuously infused Trifluridine in mice. Trifluridine gradually accumulates in tumor cell DNA, in a TPI-independent manner, and significantly delays tumor growth and prolonged survival in mice, compared to treatment with 5-FU derivatives.  Trifluridine results in significantly lower viral titers, fewer HSV-1-positive eyes/total during the treatment period, lower keratitis scores, fewer eyes with keratitis/total, and a shorter time to resolution of keratitis in the New Zealand rabbit ocular model. |
-  Yamashita F, et al. Cancer Chemother Pharmacol,?015 Jun 18.
-  Sakamoto K, et al. Int J Oncol,?015, 46(6), 2327-2334.
-  Germano A, et al. Mol燙ell燛ndocrinol,?014, 382(1), 1-7.
|In vitro||DMSO||59 mg/mL (199.18 mM)|
|Water||59 mg/mL warmed (199.18 mM)|
|Ethanol||59 mg/mL (199.18 mM)|
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
|Synonyms||NSC 529182, NSC 75520|
Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).
Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )
* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).
Molecular Weight Calculator
Enter the chemical formula of a compound to calculate its molar mass and elemental composition:
Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2
Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
Clinical Trial Information
|NCT Number||Recruitment||Conditions||Sponsor/Collaborators||Start Date||Phases|
|NCT03031691||Not yet recruiting||Metastatic Colorectal Cancer||OncoMed Pharmaceuticals, Inc.||January 2017||Phase 1|
|NCT02848443||Recruiting||Metastatic Colorectal Cancer||Institut de Recherches Internationales Servier|Servier||May 2016||Phase 1|
|NCT02743221||Recruiting||Metastatic Colorectal Cancer||Institut de Recherches Internationales Servier|Servier||April 2016||Phase 2|
|NCT01867866||Active, not recruiting||Advanced Solid Tumors||Taiho Oncology, Inc.||June 2013||Phase 1|
|NCT00000635||Completed||Herpes Simplex|HIV Infections||National Institute of Allergy and Infectious Diseases (NIAID)|Glaxo Wellcome||null||--|
|NCT00002037||Completed||Mycobacterium Avium-Intracellulare Infection|HIV Infections||Amgen|NIH AIDS Clinical Trials Information Service||null||--|
Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.